Mitochondrial Encephalomyopathies: Therapeutic Approach

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1196/annals.1293.023PMID 15126300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Treatment for mitochondrial diseases].

  2004cited by this paper
• Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial

  2004cited by this paper
• Idebenone for treatment of Friedreich’s ataxia?

  2003cited by this paper
• Idebenone treatment in Friedreich’s ataxia

  2003cited by this paper
• The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients.

  2003cited by this paper
• Mitochondrial respiratory-chain diseases.

  2003cited by this paper
• Neuronal degeneration and mitochondrial dysfunction.

  2003cited by this paper
• The yeast counterparts of human ‘MELAS’ mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF‐Tu

  2003cited by this paper
• Identical large scale rearrangement of mitochondrial DNA causes Kearns-Sayre syndrome in a mother and her son

  2003cited by this paper
• Cerebellar ataxia and coenzyme Q10 deficiency

  2003cited by this paper
• Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial

  2003cited by this paper
• Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

  2002cited by this paper
• Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.

  2002cited by this paper
• Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy

  2002cited by this paper
• Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase*

  2002cited by this paper
• An algal nucleus-encoded subunit of mitochondrial ATP synthase rescues a defect in the analogous human mitochondrial-encoded subunit.

  2002cited by this paper
• Hypertrophic cardiomyopathy and mtDNA depletion. Successful treatment with heart transplantation.

  2002cited by this paper
• Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus

  2002cited by this paper
• Mitochondrial DNA depletion and dGK gene mutations

  2002cited by this paper
• Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with pearson syndrome.

  2002cited by this paper
• Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations.

  2002cited by this paper
• Chapter 5 Mitochondrial Abnormalities in Neurodegenerative Disorders

  2002cited by this paper
• Mitochondrial abnormalities in neurodegenerative disorders

  2002cited by this paper
• Apoptosis and Oxidative Stress in Mitochondrial Disorders

  2002cited by this paper
• Aerobic conditioning in patients with mitochondrial myopathies: Physiological, biochemical, and genetic effects

  2001cited by this paper
• Mitochondria in human offspring derived from ooplasmic transplantation.

  2001cited by this paper
• Lack of Complex I Activity in Human Cells Carrying a Mutation in MtDNA-encoded ND4 Subunit Is Corrected by theSaccharomyces cerevisiae NADH-Quinone Oxidoreductase (NDI1) Gene*

  2001cited by this paper
• Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.

  2001cited by this paper
• Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children.

  2001cited by this paper
• Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

  2001cited by this paper
• The pros and cons of mitochondrial manipulation in the human germ line.

  2001cited by this paper
• Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency

  2001cited by this paper
• Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

  2001cited by this paper
• Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.

  2000cited by this paper
• Mitochondrial Respiratory Chain Diseases and Mutations in Nuclear DNA: A Promising Start?

  2000cited by this paper
• Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations

  2000cited by this paper
• Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene.

  2000cited by this paper
• Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm.

  2000cited by this paper
• Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA

  2000cited by this paper
• A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency

  1999cited by this paper
• Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.

  1999cited by this paper
• Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA.

  1999cited by this paper
• Oligomycin Induces a Decrease in the Cellular Content of a Pathogenic Mutation in the Human Mitochondrial ATPase 6 Gene*

  1999cited by this paper
• Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation

  1999cited by this paper
• Gene shifting: a novel therapy for mitochondrial myopathy.

  1999cited by this paper
• Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

  1999cited by this paper
• Peptide nucleic acid delivery to human mitochondria

  1999cited by this paper
• Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome

  1999cited by this paper
• Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry.

  1999cited by this paper
• Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA

  1999cited by this paper
• Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene

  1999cited by this paper
• Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy

  1998cited by this paper
• Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene.

  1998cited by this paper
• Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells.

  1998cited by this paper
• Cochlear origin of hearing loss in MELAS syndrome

  1998cited by this paper
• Effects of dichloroaeetate in three patients with MELAS

  1998cited by this paper
• Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment.

  1998cited by this paper
• Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids

  1997cited by this paper
• Reversal of a mitochondrial DNA defect in human skeletal muscle

  1997cited by this paper
• A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

  1997cited by this paper
• Mitochondrial encephalomyopathy with coenzyme Q10 deficiency

  1997cited by this paper
• Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy.

  1997cited by this paper
• Concomitant administration of sodium dichloroacetate and vitamin B1 for lactic acidemia in children with MELAS syndrome.

  1997cited by this paper
• Multiple mitochondria1 DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy

  1996cited by this paper
• Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency

  1996cited by this paper
• A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy.

  1996cited by this paper
• A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria

  1996cited by this paper
• Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS

  1996cited by this paper
• Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders

  1995cited by this paper
• Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation

  1995cited by this paper
• Valproic Acid Impairs Carnitine Uptake in Cultured Human Skin Fibroblasts. An In Vitro Model for the Pathogenesis of Valproic Acid–Associated Carnitine Deficiency

  1993cited by this paper
• Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome.

  1993cited by this paper
• Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion.

  1993cited by this paper
• 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies

  1992cited by this paper
• Muscle coenzyme Q10 in mitochondrial encephalomyopathies.

  1991cited by this paper
• Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake

  1991cited by this paper
• Impaired Skin Fibroblast Carnitine Uptake in Primary Systemic Carnitine Deficiency Manifested by Childhood Carnitine-Responsive Cardiomyopathy

  1990cited by this paper
• Copper Histidinate Therapy in Menkes’ Disease: Prevention of Progressive Neurodegeneration

  1989cited by this paper
• Mitochondrial diseases.

  1989cited by this paper
• The pharmacology of dichloroacetate.

  1989cited by this paper
• Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

  1989cited by this paper
• Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone.

  1989cited by this paper
• Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10

  1988cited by this paper
• Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration.

  1987cited by this paper
• Treatment of Kearns‐Sayre syndrome with coenzyme Q10

  1986cited by this paper
• Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study

  1986cited by this paper
• 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

  1984cited by this paper
• Lactic Acidosis and Mitochondrial Myopathy Associated with Deficiency of Several Components of Complex III of the Respiratory Chain

  1984cited by this paper
• Kearns‐sayre syndrome with reduced plasma and cerebrospinal fluid folate

  1983cited by this paper
• Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case.

  1976cited by this paper
• Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria.

  1971cited by this paper

• Mitochondrial DNA involvement in patients with autism spectrum disorders and intellectual disability

  2023cites this paper
• Mitochondrial Calcium: Effects of Its Imbalance in Disease

  2022cites this paper
• Detecting respiratory chain defects in osteoblasts from osteoarthritic patients using imaging mass cytometry.

  2022cites this paper
• Hypometabolic Responses to Chronic Hypoxia: A Potential Role for Membrane Lipids

  2021cites this paper
• Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease

  2021cites this paper
• Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging.

  2021cites this paper
• Mutational Analysis and mtDNA Haplogroup Characterization in Three Serbian Cases of Mitochondrial Encephalomyopathies and Literature Review

  2021cites this paper
• Mitochondrial dysfunction in metabolic disorders

  2021cites this paper
• Mitochondrial DNA A3243G variant-associated retinopathy: a meta-analysis of the clinical course of visual acuity and correlation with systemic manifestations

  2021cites this paper
• Approaches to monitor ATP levels in living cells: where do we stand?

  2021cites this paper
• Cellular mechanisms of mtDNA heteroplasmy dynamics

  2021cites this paper
• Association of Pathogenic Missense and Nonsense Mutations in Mitochondrial COII Gene with Familial Adenomatous Polyposis (FAP)

  2021cites this paper
• Mitochondrial disease in children

  2020cites this paper
• Clinical features of mitochondrial encephalomyopathies in China: 97 case study and literature review

  2020cites this paper
• Histochemical and immunohistochemical staining methods to visualize mitochondrial proteins and activity.

  2020cites this paper
• Linear Skin Defects with Multiple Congenital Anomalies (LSDMCA): An Unconventional Mitochondrial Disorder

  2020cites this paper
• A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy

  2020cites this paper
• Kearns Sayer Syndrome- A Case Report

  2020cites this paper
• Drug Treatment of Progressive Myoclonic Epilepsy

  2020cites this paper
• Systemic Delivery of AAV-Fdxr Mitigates the Phenotypes of Mitochondrial Disorders in Fdxr Mutant Mice

  2020cites this paper
• Naked mole-rats suppress energy metabolism and modulate membrane cholesterol in chronic hypoxia.

  2020cites this paper
• Mitochondrial Genetic Drift after Nuclear Transfer in Oocytes

  2020cites this paper
• Cryogenic electron paramagnetic resonance spectroscopy of flash-frozen tissue for characterization of mitochondrial disease

  2020cites this paper
• tRNA Metabolism and Neurodevelopmental Disorders.

  2019cites this paper
• Sleep and circadian defects in a Drosophila model of mitochondrial encephalomyopathy

  2019cites this paper
• Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes – a case report

  2019cites this paper
• Targeting Mitochondria for Therapy of Cardiovascular Disease

  2019cites this paper
• Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy.

  2019cites this paper
• Beneficiality of combined levetiracetam, clonazepam for myoclonus in MERRF requires further confirmation

  2019cites this paper
• When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases

  2019cites this paper
• Investigating gene mutations in a South African paediatric cohort diagnosed with mitochondrial disease

  2019cites this paper
• Mitochondrial Biology and Medicine

  2019cites this paper
• mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

  2019cites this paper
• Different Biological Pathways Are Up-regulated in the Elderly With Asthma: Sputum Transcriptomic Analysis

  2018cites this paper
• Antimyoclonic Effect of Levetiracetam and Clonazepam Combined Treatment on Myoclonic Epilepsy with Ragged-Red Fiber Syndrome with m.8344A>G Mutation

  2018cites this paper
• Mitochondrial Encephalopathy: First Portuguese Report of a VARS2 Causative Variant.

  2018influential citation
• Metabolic screening and its impact in children with nonsyndromic intellectual disability

  2017cites this paper
• Coenzyme Q10 in the Treatment of Mitochondrial Disease

  2017cites this paper
• Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency

  2017cites this paper
• MITOCHONDRIELE ENCEFALOMYOPATH1E, LACTAATACIDOSE EN STROKE-LIKE EPISODES (MELAS): EEN ZELDZAME OORZAAK VAN „STROKE” OP JONGVOLWASSEN LEEFTIJD

  2017cites this paper
• The ATP-sensitive K channel is seizure protective and required for effective dietary therapy in a model of mitochondrial encephalomyopathy

  2016cites this paper
• Amelioration of energy metabolism by melatonin in skeletal muscle of rats with LPS induced endotoxemia.

  2016cites this paper
• The Neurology Of Autism

  2016cites this paper
• Inherited and acquired disorders of myelin: The underlying myelin pathology

  2016cites this paper
• Drug-Induced Mitochondrial Toxicity

  2016cites this paper
• Anästhesiologische Besonderheiten bei Patienten mit MELAS-Syndrom

  2015cites this paper
• [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

  2015cites this paper
• A novel m.7539C>T point mutation in the mt-tRNAAsp gene associated with multisystemic mitochondrial disease

  2015cites this paper
• Pathogenic mitochondrial mt-tRNAAla variants are uniquely associated with isolated myopathy

  2015cites this paper
• Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome

  2014cites this paper
• Şizofreni ve Mitokondri Disfonksiyonu Schizophrenia and Mitochondria Dysfunction

  2014cites this paper
• Treatment of Mitochondrial Disorders

  2014cites this paper
• Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation.

  2014cites this paper
• Coenzyme Q10 as a therapy for mitochondrial disease.

  2014cites this paper
• Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

  2014cites this paper
• Loss of UCP2 Attenuates Mitochondrial Dysfunction without Altering ROS Production and Uncoupling Activity

  2014cites this paper
• Two-Dimensional Evaluations for Mitochondrial Number Are Not Reliable

  2013cites this paper
• Thymidine Kinase 2 Deficiency-Induced mtDNA Depletion in Mouse Liver Leads to Defect β-Oxidation

  2013cites this paper
• Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes in a Japanese child: Clinical, radiological and molecular genetic analysis

  2013influential citation
• Cytogenetic studies of chromosomal breakage diseases

  2013cites this paper
• Mitochondrial DNA depletion may also have a role in pathogenesis of osteosarcoma

  2013cites this paper
• Targeting the Mitochondria in Cardiovascular Diseases

  2013cites this paper
• Early Spinal Cord and Brainstem Involvement in Infantile Leigh Syndrome Possibly Caused by a Novel Variant

  2013cites this paper
• Supporting the generalist genes hypothesis for intellectual ability/disability: the case of SNAP25

  2012cites this paper
• A possible role for mitochondrial dysfunction in migraine

  2012cites this paper
• Endothelial dysfunction and increased oxidative stress in mitochondrial diseases.

  2012cites this paper
• Mitochondrial Mutations in Essential Hypertension

  2012cites this paper
• Heat shock protein 70 (Hsp70) inhibits oxidative phosphorylation and compensates ATP balance through enhanced glycolytic activity.

  2012cites this paper
• Counting mitochondria using electron microscopy

  2012cites this paper
• Mitochondrial Calcium Signalling: Role in Oxidative Phosphorylation Diseases

  2012cites this paper
• Mitochondrial DNA and Heart Disease

  2011cites this paper
• Relationships among Processing Speed, Attention, and Biochemical Features in Children Identified with Mitochondrial Disease

  2011cites this paper
• A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations

  2011cites this paper
• VDAC3 has differing mitochondrial functions in two types of striated muscles.

  2011cites this paper
• Disruption of Endothelial Tight Junctions in a Patient with Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS)

  2010cites this paper
• Treatment of mitochondrial disorders.

  2010cites this paper
• Drug management in emergent liver transplantation of mitochondrial disorder carriers: review of the literature

  2010cites this paper
• Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect

  2010cites this paper
• Bezafibrate induced increase in mitochondrial electron transport chain complex IV activity in human astrocytoma cells: Implications for mitochondrial cytopathies and neurodegenerative diseases

  2010cites this paper
• Increased Protein Nitration in Mitochondrial Diseases: Evidence for Vessel Wall Involvement

  2010cites this paper
• De Toni-Debré-Fanconi syndrome in a patient with Kearns-Sayre syndrome: a case report

  2009cites this paper
• EFNS guidelines on the molecular diagnosis of mitochondrial disorders

  2009cites this paper
• Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

  2009cites this paper
• Extensive remyelination of the CNS leads to functional recovery

  2009cites this paper
• Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS

  2009cites this paper
• Mitochondrial dysfunction and psychiatric disorders.

  2009cites this paper
• Accumulation of oxidative stress around the stroke-like lesions of MELAS patients.

  2009cites this paper
• Identification of ataxia‐associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in transmitochondrial cybrids

  2009cites this paper
• Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.

  2009cites this paper
• [Leigh syndrome: case report].

  2008cites this paper
• Effects of hyperbaric oxygen on energy production and xanthine oxidase levels in striated muscle tissue of healthy rats.

  2008cites this paper
• Maternally inherited deafness and unusual phenotypic manifestations associated with A3243G mitochondrial DNA mutation

  2008cites this paper
• Statin Adverse Effects

  2008cites this paper
• Mitochondrial involvement in psychiatric disorders

  2008influential citation
• Mitochondrial respiratory chain defects: Underlying etiology in various epileptic conditions

  2008cites this paper
• A 23-year-old man with seizures and visual deficit

  2008cites this paper
• REV.MEDICA VOL.19 NOV.indd

  2008cites this paper
• Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder

  2008cites this paper
• Role of phenylalanyl-tRNA synthetase in translation quality control

  2008influential citation
• How can we treat mitochondrial encephalomyopathies? approaches to therapy

  2008cites this paper